Gene · 10561
Papers3,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory NK cells in autoimmune disease. | Iran J Basic Med Sci | 2023 | 37275764 | PubTator, text mining | PubMed |
| Cholangiokines: undervalued modulators in the hepatic microenvironment. | Front Immunol | 2023 | 37261338 | PubTator, text mining | PubMed |
| Axonemal structures reveal mechanoregulatory and disease mechanisms. | Nature | 2023 | 37258679 | PubTator, text mining | PubMed |
| TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1. | Exp Mol Med | 2023 | 37258577 | PubTator, text mining | PubMed |
| PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production. | Sci Transl Med | 2023 | 37256937 | PubTator, text mining | PubMed |
| Accelerated replicative senescence of ataxia-telangiectasia skin fibroblasts is retained at physiologic oxygen levels, with unique and common transcriptional patterns. | Aging Cell | 2023 | 37254625 | PubTator, text mining | PubMed |
| Transcriptional changes in multiple endocrine organs from lethal cases of COVID-19. | J Mol Med (Berl) | 2023 | 37246981 | PubTator, text mining | PubMed |
| Mechanism of Immune Evasion in Mosquito-Borne Diseases. | Pathogens | 2023 | 37242305 | PubTator, text mining | PubMed |
| CAGE sequencing reveals CFTR-dependent dysregulation of type I IFN signaling in activated cystic fibrosis macrophages. | Sci Adv | 2023 | 37235648 | PubTator, text mining | PubMed |
| Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells. | Oncoimmunology | 2023 | 37235066 | PubTator, text mining | PubMed |
| Transposable elements are associated with the variable response to influenza infection. | Cell Genom | 2023 | 37228757 | PubTator, text mining | PubMed |
| Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion. | Nat Commun | 2023 | 37225706 | PubTator, text mining | PubMed |
| B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy children. | Lupus Sci Med | 2023 | 37202122 | PubTator, text mining | PubMed |
| Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection. | Front Immunol | 2023 | 37197656 | PubTator, text mining | PubMed |
| The IFN-stimulated gene IFI27 counteracts innate immune responses after viral infections by interfering with RIG-I signaling. | Front Microbiol | 2023 | 37187533 | PubTator, text mining | PubMed |
| The E3 Ubiquitin Ligase TRIM21 Regulates Basal Levels of PDGFRβ. | Int J Mol Sci | 2023 | 37175489 | PubTator, text mining | PubMed |
| Expression of L1 retrotransposons in granulocytes from patients with active systemic lupus erythematosus. | Mob DNA | 2023 | 37165451 | PubTator, text mining | PubMed |
| Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. | Exp Hematol Oncol | 2023 | 37158921 | PubTator, text mining | PubMed |
| Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab. | Clin Pharmacokinet | 2023 | 37148484 | PubTator, text mining | PubMed |
| Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment. | J Immunother Cancer | 2023 | 37147019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10561/papers?page=14